2751 - 2775 of 8819 Results
Title
Year
-
OPENTitle: Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2Journal Name: CellsPublisher: MDPI AGVol: 13Issue #: 1Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13010053Best OA location URL: https://www.mdpi.com/2073-4409/13/1/53/pdf?version=1703658023Citation Count: 0
-
OPENTitle: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 704End Page: 717Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11481-023-10094-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-023-10094-7.pdfCitation Count: 5
-
OPENTitle: Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodiesJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-023-05725-xBest OA location URL: https://www.nature.com/articles/s42003-023-05725-x.pdfCitation Count: 4
-
OPENTitle: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 34Issue #:Start Page: 103022End Page: 103022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103022Citation Count: 27
-
OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 2
-
OPENTitle: Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00317-8Best OA location URL: https://www.nature.com/articles/s41531-022-00317-8.pdfCitation Count: 4
-
OPENTitle: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth ApplicationsJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 2Start Page: 71End Page: 82Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000525698Best OA location URL: https://www.karger.com/Article/Pdf/525698Citation Count: 5
-
OPENTitle: Spatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomicsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 6112End Page: 6112Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-33881-xBest OA location URL: https://www.nature.com/articles/s41467-022-33881-x.pdfCitation Count: 47
-
OPENTitle: Using former carers’ expertise in peer support for carers of people with Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 133End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00381-0Best OA location URL: https://www.nature.com/articles/s41531-022-00381-0.pdfCitation Count: 14
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 17314End Page: 17314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://hdl.handle.net/2292/62394Citation Count: 28
- [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease2022OPENTitle: [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 19Start Page: 3081End Page: 3081Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11193081Best OA location URL: https://www.mdpi.com/2073-4409/11/19/3081/pdf?version=1664531627Citation Count: 9
-
OPENTitle: Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivoJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 144Issue #: 5Start Page: 881End Page: 910Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-022-02491-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-022-02491-8.pdfCitation Count: 31
- Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease2022OPENTitle: Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 961End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13533Citation Count: 5
-
OPENTitle: Deficiency of the frontotemporal dementia gene GRN results in gangliosidosisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 5924End Page: 5924Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-33500-9Best OA location URL: https://www.nature.com/articles/s41467-022-33500-9.pdfCitation Count: 95
- Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms2022OPENTitle: Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive SymptomsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1644End Page: 1653Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29128Best OA location URL: https://doi.org/10.1002/mds.29128Citation Count: 107
-
OPENTitle: Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomesJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 5Start Page: 112448End Page: 112448Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112448Best OA location URL: http://www.cell.com/article/S221112472300459X/pdfCitation Count: 28
-
OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15
-
OPENTitle: Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10359Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10359/pdfCitation Count: 36
-
OPENTitle: PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domainJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 18Start Page: 1941End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220308Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/18/1941/937618/bcj-2022-0308.pdfCitation Count: 12
-
OPENTitle: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signalsJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2207End Page: 2215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-022-01932-xBest OA location URL: https://www.nature.com/articles/s41591-022-01932-x.pdfCitation Count: 259
-
OPENTitle: Fecal microbiome alterations in treatment-naive de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 129End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00395-8Best OA location URL: https://www.nature.com/articles/s41531-022-00395-8.pdfCitation Count: 28
-
OPENTitle: Identification of risk genes for Alzheimer’s disease by gene embeddingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 9Start Page: 100162End Page: 100162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100162Citation Count: 24
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 919778End Page: 919778Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 13
-
OPENTitle: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 134End Page: 134Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00400-0Best OA location URL: https://www.nature.com/articles/s41531-022-00400-0.pdfCitation Count: 18
-
OPENTitle: Lipid pathway dysfunction is prevalent in patients with Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 10Start Page: 3472End Page: 3487Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac176Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac176/45231989/awac176.pdfCitation Count: 125